Bryan Morris

Bryan Morris is a seasoned professional in regulatory affairs with significant experience in CMC (Chemistry, Manufacturing, and Controls) across various biopharmaceutical organizations. Currently serving as Senior Director of CMC Regulatory Affairs at Tourmaline Bio, Bryan has developed strategies for regulatory submissions and facilitated drug product transitions. Prior roles include Director of Regulatory CMC at GentiBio, where leadership was provided for FDA meeting preparations, and Associate Director of Regulatory Affairs at Juno Therapeutics, focusing on compliance with FDA regulations and training activities. Additional experience includes consultancy work at Dendreon Pharmaceuticals and founding BMBD, LLC, offering regulatory oversight and strategic advice. Bryan's academic credentials include an MS in Biomedical Regulatory Affairs from the University of Washington and a BS in Biology from Pacific Lutheran University.